Secondary Logo

Journal Logo

January 2007 - Volume 33 - Issue 1
pp: 1-129

Interferon Alfa-2b or Not 2b? Significant Differences Exist in the Decision-Making Process between Melanoma Patients Who Accept or Decline High-Dose Adjuvant Interferon Alfa-2b Treatment

BRAMLETTE, TRACY B.; LAWSON, DAVID H.; WASHINGTON, CARL V.; More

Dermatologic Surgery. 33(1):11-16, January 2007.








Show: